Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563610 · ClinicalTrials.gov registry record · Phase 4
Oral Penicillin Challenge and Allergy De-labeling in Children
A Phase 4 study, sponsored by Phoenix Children's Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT05563610 is a Phase 4 study that was terminated before completion, run by Phoenix Children's Hospital. The registered enrollment target is 31 participants.
The verdict
NCT05563610, a Phase 4 study, was terminated before completion, sponsored by Phoenix Children's Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in the Pediatric Emergency Department.
Interventions
- DRUG Amoxicillin 500mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2024-06-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05563610
The ClinicalTrials.gov registry entry for NCT05563610 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amoxicillin 500mg is the first listed.
NCT05563610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05563610 about?
NCT05563610 is a clinical study titled "Oral Penicillin Challenge and Allergy De-labeling in Children". The primary purpose of this study is to investigate the portion of penicillin allergy labels that are not true allergies using oral amoxicillin challenges among pediatric patients. The secondary purpose is to evaluate the safety and feasibility of administering oral penicillin allergy challenges in ...
What is the current status of trial NCT05563610?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2022-09-26. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT05563610?
The interventions under investigation include: Amoxicillin 500mg (DRUG).
Who is sponsoring clinical trial NCT05563610?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.